Project cooperation
We seek partners to validate and scale OliQuell™, a nature-based CH₄/H₂S reducer and water-cleaning agent made from olive waste.
President & CEO
Veos Pharmaceuticals, SL
Madrid, Madrid, Spain
We develop OliQuell™-coated filters that cut CO₂, VOCs, and odors in sealed recirculating systems for mobility, HVAC, industry, and oil & gas
Dr. Bassam Damaj is a biotech entrepreneur and pharmaceutical innovator with over 25 years of experience building science-based ventures.
He has founded 7 companies, led 3 IPOs, and raised over $500M across the U.S., EU, and MENA.
As CEO of Veos Pharmaceuticals, he leads the development of ThymoTropin™, the first natural and clinically validated myostatin regulator, designed to combat sarcopenia by preserving muscle growth, strength, and endurance in aging populations.
His expertise spans biotechnology, functional ingredients, clinical development, and global strategic partnerships — with a focus on healthy aging and longevity.
Project cooperation
We seek partners to validate and scale OliQuell™, a nature-based CH₄/H₂S reducer and water-cleaning agent made from olive waste.
Product
ThymoTropin™ – Natural Myostatin-Regulating Ingredient for Muscle Health
Clinically validated natural ingredient targeting sarcopenia by regulating myostatin and boosting strength, mobility, and endurance.
Product
OliQuell™ – Scalable Carbon Capture, Water Treatment & Biogas Cleaning
Natural CO₂ capture, gas neutralization, water & biogas purification from olive waste—ideal for Japan’s clean energy transition.